Sun Pharmaceutical Industries Ltd. will acquire 100% of Antibe Therapeutics Inc., a clinical-stage biotechnology company, with a turnover of NIL for FY 2023-24, subject to regulatory approval, expected to complete by March 7, 2025.
AI Assistant
Sun Pharmaceuticals Industries Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.